Zacks Investment Research downgraded shares of CME Group Inc. (CME) from OUTPERFORM to NEUTRAL on November 18, 2013, with a target price of $84.00.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on CME Group Inc. (CME),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment